Tempus AI’s (TEM) Market Perform Rating Reaffirmed at William Blair

William Blair reiterated their market perform rating on shares of Tempus AI (NASDAQ:TEM) in a report issued on Tuesday,RTT News reports.

Several other equities analysts have also commented on the stock. JPMorgan Chase & Co. lowered shares of Tempus AI from an “overweight” rating to a “neutral” rating and increased their price target for the company from $50.00 to $55.00 in a research note on Tuesday. Stifel Nicolaus downgraded shares of Tempus AI from a “buy” rating to a “hold” rating and increased their target price for the company from $45.00 to $65.00 in a research report on Monday, November 11th. Needham & Company LLC lifted their price target on shares of Tempus AI from $56.00 to $70.00 and gave the stock a “buy” rating in a research note on Tuesday. Guggenheim restated a “buy” rating on shares of Tempus AI in a research note on Tuesday. Finally, TD Cowen reiterated a “buy” rating and set a $74.00 target price (up previously from $58.00) on shares of Tempus AI in a research report on Wednesday, February 5th. Five research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $60.55.

Tempus AI Stock Performance

TEM opened at $55.30 on Tuesday. The company has a current ratio of 2.69, a quick ratio of 2.55 and a debt-to-equity ratio of 8.17. Tempus AI has a one year low of $22.89 and a one year high of $91.45. The business’s 50-day simple moving average is $52.29 and its 200-day simple moving average is $52.27.

Insider Buying and Selling

In other Tempus AI news, CAO Ryan M. Bartolucci sold 13,770 shares of the business’s stock in a transaction that occurred on Friday, January 31st. The stock was sold at an average price of $60.00, for a total transaction of $826,200.00. Following the transaction, the chief accounting officer now owns 57,237 shares in the company, valued at approximately $3,434,220. The trade was a 19.39 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO Eric P. Lefkofsky sold 3,240,234 shares of the company’s stock in a transaction on Thursday, February 27th. The stock was sold at an average price of $58.75, for a total value of $190,363,747.50. Following the transaction, the chief executive officer now directly owns 4,895,589 shares in the company, valued at $287,615,853.75. This represents a 39.83 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 5,823,701 shares of company stock valued at $320,906,059 over the last quarter.

Hedge Funds Weigh In On Tempus AI

Large investors have recently made changes to their positions in the stock. ARK Investment Management LLC boosted its position in Tempus AI by 132.1% during the fourth quarter. ARK Investment Management LLC now owns 5,519,644 shares of the company’s stock worth $186,343,000 after purchasing an additional 3,141,487 shares in the last quarter. Sumitomo Mitsui Trust Group Inc. increased its holdings in Tempus AI by 166.0% during the 4th quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,239,093 shares of the company’s stock valued at $109,352,000 after acquiring an additional 2,021,394 shares in the last quarter. Nikko Asset Management Americas Inc. lifted its holdings in shares of Tempus AI by 166.0% in the fourth quarter. Nikko Asset Management Americas Inc. now owns 3,239,093 shares of the company’s stock valued at $109,352,000 after purchasing an additional 2,021,394 shares in the last quarter. Franklin Resources Inc. grew its position in shares of Tempus AI by 240.5% in the fourth quarter. Franklin Resources Inc. now owns 2,762,173 shares of the company’s stock valued at $93,251,000 after purchasing an additional 1,950,862 shares during the last quarter. Finally, JPMorgan Chase & Co. increased its stake in shares of Tempus AI by 86,947.2% during the 4th quarter. JPMorgan Chase & Co. now owns 1,653,896 shares of the company’s stock worth $55,836,000 after purchasing an additional 1,651,996 shares in the last quarter. Hedge funds and other institutional investors own 24.22% of the company’s stock.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.